Inhibition of mammary carcinogenesis by flurbiprofen, a non-steroidal antiinflammatory agent
Authors:
- D L McCormickDMD L McCormick
- R C MoonRMR C Moon
- 1 December 1983
- journal article
- research article
- Published by Springer Nature in British Journal of Cancer
- Vol. 48 (6) , 859-861
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Increased survival of cancer-bearing mice treated with inhibitors of prostaglandin synthesis alone or with chemotherapyBritish Journal of Cancer, 1982
- Effect of Indomethacin on Intestinal Tumors Induced in Rats by the Acetate Derivative of DimethylnitrosamineScience, 1981
- Possible involvement of arachidonic acid in the initiation of DNA synthesis by rat liver cellsExperimental Cell Research, 1980
- The effects of non-steroid anti-inflammatory drugs on leukocyte migration in carrageenin-induced inflammationEuropean Journal of Pharmacology, 1980
- Indomethacin-sensitive suppressor cells regulate the cell-mediated cytotoxic response to SV 40-induced tumor-associated antigens in miceEuropean Journal of Immunology, 1980
- FlurbiprofenDrugs, 1979
- Breast cancer and prostaglandins: A new approach to treatmentBritish Journal of Surgery, 1979
- Improved anticancer effect by combining cytotoxic drugs with an inhibitor of prostaglandin synthesisCancer Treatment Reviews, 1979
- Enhancement of natural and antibody-dependent lymphocyte cytotoxicity by drugs which inhibit prostaglandin production by tumor target cellsCellular Immunology, 1978
- Enhancement of anti-cancer activity of cytotoxic chemotherapy with protection of normal tissues by inhibition of P.G. synthesisBiochemical Pharmacology, 1978